Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hanzhe, Zheng"'
Autor:
Anil, Gupta, Yaneicy, Gonzalez-Rojas, Erick, Juarez, Manuel, Crespo Casal, Jaynier, Moya, Diego, Rodrigues Falci, Elias, Sarkis, Joel, Solis, Hanzhe, Zheng, Nicola, Scott, Andrea L, Cathcart, Sergio, Parra, Jennifer E, Sager, Daren, Austin, Amanda, Peppercorn, Elizabeth, Alexander, Wendy W, Yeh, Cynthia, Brinson, Melissa, Aldinger, Adrienne E, Shapiro, Lawrence, Sher
Publikováno v:
JAMA
IMPORTANCE: Older patients and those with comorbidities who are infected with SARS-CoV-2 may be at increased risk of hospitalization and death. Sotrovimab is a neutralizing antibody for the treatment of high-risk patients to prevent COVID-19 progress
Autor:
Anil Gupta, Manuel Crespo, Daren Austin, Adrienne E. Shapiro, Erick Juarez, Jennifer Sager, Joel Solis, Elizabeth Alexander, Amanda Peppercorn, Yaneicy Gonzalez-Rojas, Cynthia Brinson, Hanzhe Zheng, Nicola Scott, Elias Sarkis, Melissa Aldinger, Andrea L. Cathcart, Jaynier Moya, Diego R. Falci, Sergio Parra, Wendy W. Yeh
ImportanceOlder patients and those with underlying comorbidities infected with SARS-CoV-2 may be at increased risk of hospitalization and death from COVID-19. Sotrovimab is a neutralizing antibody designed for treatment of high-risk patients to preve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a11230f5e0001f5702dcccf0ad2543a0
https://doi.org/10.1101/2021.11.03.21265533
https://doi.org/10.1101/2021.11.03.21265533
Autor:
Anil, Gupta, Yaneicy, Gonzalez-Rojas, Erick, Juarez, Manuel, Crespo Casal, Jaynier, Moya, Diego R, Falci, Elias, Sarkis, Joel, Solis, Hanzhe, Zheng, Nicola, Scott, Andrea L, Cathcart, Christy M, Hebner, Jennifer, Sager, Erik, Mogalian, Craig, Tipple, Amanda, Peppercorn, Elizabeth, Alexander, Phillip S, Pang, Almena, Free, Cynthia, Brinson, Melissa, Aldinger, Adrienne E, Shapiro, Luis, Zepeda
Publikováno v:
The New England journal of medicine. 385(21)
Coronavirus disease 2019 (Covid-19) disproportionately results in hospitalization or death in older patients and those with underlying conditions. Sotrovimab is a pan-sarbecovirus monoclonal antibody that was designed to prevent progression of Covid-
Autor:
Anil Gupta, Erik Mogalian, Yaneicy Gonzalez-Rojas, Manuel Crespo Casal, Melissa Aldinger, Elizabeth Alexander, Elias Sarkis, Amanda Peppercorn, Hanzhe Zheng, Christy M. Hebner, Joel Solis, Nicola Scott, Craig Tipple, Andrea L. Cathcart, Diego R. Falci, Adrienne E. Shapiro, Almena Free, Jennifer Sager, Jaynier Moya, Phillip S. Pang, Cynthia Brinson, Erick Juarez
BackgroundCoronavirus disease 2019 (Covid-19) disproportionately results in hospitalization and death in older patients and those with underlying comorbidities. Sotrovimab is a pan-sarbecovirus monoclonal antibody designed to treat such high-risk pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdcbc8747e377498858eb2160f81d3a4
https://doi.org/10.1101/2021.05.27.21257096
https://doi.org/10.1101/2021.05.27.21257096
Autor:
Jerry S. Wolinsky, Harold Köndgen, Ludwig Kappos, Michael K. Racke, Laura Julian, Lori Mayer, Carrie Li, Hanzhe Zheng, Stephen L. Hauser, Anthony Traboulsee, Kottil Rammohan, Julie Napieralski
Publikováno v:
Multiple Sclerosis and Related Disorders. 30:236-243
Background Ocrelizumab is an infusible humanized monoclonal antibody that selectively depletes CD20+ B cells. Infusion-related reactions (IRRs) were summarized from the OPERA I, OPERA II, and ORATORIO trials for relapsing and primary progressive mult
Autor:
Anil K Gupta, Yaneicy Gonzalez Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya, Diego Rodrigues Falci, Elias H Sarkis, Joel Solis, Hanzhe Zheng, Nicola Scott, Andrea L Cathcart, Christy Hebner, Jennifer Sager, Erik Mogalian, Daren Austin, Amanda Peppercorn, Elizabeth L Alexander, Wendy W Yeh, Almena Free, Cynthia Brinson, Melissa Aldinger, Adrienne Shapiro
Publikováno v:
Open Forum Infectious Diseases
Background COVID-19 disproportionately results in hospitalization and death in older patients and those with underlying comorbidities. Sotrovimab is a pan-sarbecovirus monoclonal antibody that binds a highly conserved epitope of the SARS-CoV-2 recept
Autor:
Hanzhe Zheng, Joaquim Bellmunt, Jean H. Hoffman-Censits, Darren Tayama, Sumanta K. Pal, Constanze Kaiser
Publikováno v:
European Urology. 73:800-806
Atezolizumab (anti-programmed death-ligand 1) was approved in the USA, Europe, and elsewhere for treatment-naive and platinum-treated locally advanced/metastatic urothelial carcinoma (mUC).To report efficacy and safety from an atezolizumab expanded a
Autor:
Hanzhe Zheng, Michael Y. Choi, Richy Agajanian, Kerry A. Rogers, Joshua J. Field, Catherine Broome, Robert P. Numerof, Irina Murakhovskaya, David J. Kuter, Sandy Tong, Donald M. Arnold, Donna Chow, Michael Boxer
Publikováno v:
Blood. 134:3518-3518
Introduction. wAIHA is a rare and often serious disease in which red blood cells (RBCs) coated with autoantibodies bind to Fcγ receptor-bearing macrophages, triggering a spleen tyrosine kinase (SYK) dependent signaling pathway that leads to RBC phag
Autor:
Laurence Flint, Kristian Reich, Gottfried Wozel, Jonathan Barker, Hanzhe Zheng, H. J. F. van Hoogstraten
Publikováno v:
British Journal of Dermatology. 168:1325-1334
SummaryBackground Continuous maintenance therapy with infliximab 5 mg kg−1 every 8 weeks is effective for moderate-to-severe plaque-type psoriasis. Objectives To evaluate the efficacy and safety of continuous vs. intermittent infliximab maintenance
Autor:
Kristian Reich, Hanzhe Zheng, Ortonne Jp, H. J. F. van Hoogstraten, Jonathan Barker, Gottfried Wozel, Maurice Hoffmann
Publikováno v:
British Journal of Dermatology. 165:1109-1117
Summary Background Infliximab is indicated for treatment of moderate-to-severe plaque psoriasis in adults whose disease cannot be controlled with other systemic therapies, including methotrexate (MTX). To date, no studies have directly compared the e